Cryoport ‘head and shoulders above’ competitors in cryogenics, says BTIG

After having recently took a tour of Cryoport’s Global Supply Chain Center, BTIG analyst David Larsen tells investors that he came away "convinced" that Cryoport is the category leader in ultra-cold and cryogenic logistics and shipping and is "head and shoulders above several competitors" in the space. The analyst, who said he was impressed with the extent of the infrastructure, technology, staffing, and overall capabilities of the plant in New Jersey, also contends that it is "clear to us that the allogeneic industry is a reality." Larsen keeps a Buy rating and $40 price target on Cryoport shares.